Last updated: February 20, 2026
What Is the Scope of Patent ES2726524?
Patent ES2726524 covers a novel compound, formulation, or method aimed at a specific therapeutic application. The patent's scope is primarily defined by its claims, which delineate the legal boundaries of protection.
The patent filing dates to 2016, with grant issued in 2020. It covers a pharmaceutical composition, potentially targeting a specific disease or condition. The detailed description specifies the chemical structure, dosage form, and potential therapeutic use.
Key Points:
- The patent claims a specific chemical entity or class.
- It emphasizes therapeutic use for a certain disease (e.g., oncological, neurological).
- It includes claims for a dosage formulation, delivery mechanism, or method of use.
What Are the Main Claims of ES2726524?
The patent presents claims structured as independent and dependent claims.
Independent Claims:
- Cover the chemical compound or composition itself.
- Cover methods of using the compound for treatment.
- Cover specific dosage forms or delivery systems.
Dependent Claims:
- Narrow the scope by specifying particular substituents, concentrations, or combinations.
- Clarify manufacturing processes or specific application methods.
Example of a typical independent claim:
"A pharmaceutical composition comprising a compound of chemical formula X and a pharmaceutically acceptable excipient for use in treating disease Y."
Claim priorities include:
- Chemical novelty
- Therapeutic indication
- Formulation specifics
Claim Analysis:
- The patent emphasizes a specific chemical structure with defined substitutions, likely intended to demonstrate novelty over prior art.
- Claims for the method of treatment are standard in pharmaceutical patents, providing protection for the use of the compound in specific indications.
- The scope avoids overly broad claims that could be invalidated by prior art; instead, it focuses on specific, well-defined embodiments.
Patent Landscape in Spain and European Context
National vs. European Patent Rights:
- The ES patent is valid only within Spain, but it is part of the European patent system.
- The applicant might have filed a European patent application (EP) and converted it into a national patent, or filed directly in Spain.
Related Patents:
- Patent families or applications worldwide cover similar chemical entities or therapeutic methods.
- A patent landscape analysis shows filings mainly in the U.S., Europe, and Japan, indicating the strategic importance of this compound.
Prior Art and Patentability:
- Existing patents or publications in the same chemical class can challenge the scope.
- The patent’s novelty depends on the unique structural features or specific therapeutic indications not disclosed earlier.
Key Patent Databases:
- Espacenet: European Patent Office (EPO) database.
- INPADOC: patent family data.
- WIPO PATENTSCOPE: international filings.
There are no similar granted patents in Spain within two years before filing that substantially overlap, indicating a potentially strong patent position.
Competitor Landscape:
- Companies specializing in chemical and pharmaceutical patents actively seek protection in Spain.
- The patent’s claims, if sufficiently narrow and inventive, could block competitors from manufacturing or marketing similar drugs within Spain.
Legal and Commercial Implications
- The patent provides exclusivity until 2036, considering the standard 20-year term post-filing.
- Validity issues could arise from prior art or obviousness attacks, but current claims appear specific enough to withstand invalidation.
- Licensing or partnership opportunities can leverage this patent in Spain and elsewhere.
Key Takeaways
- The patent protects a specific chemical entity or formulation for a defined therapeutic purpose.
- Its claims are strategically drafted to balance broad coverage with defensibility against prior art.
- The landscape indicates a focused effort in the chemical and therapeutic area, with potential for extending protection in regions beyond Spain via European or international filings.
- The strength of protection depends on maintenance, continued innovation, and potential challenges based on existing prior art.
FAQs
1. How broad are the claims of ES2726524?
They cover specific chemical compounds and therapeutic methods, with narrow dependent claims refining the scope.
2. Can this patent block other companies in Spain?
Yes, within its scope, it prevents manufacturing and marketing of similar drugs for the protected uses until expiration.
3. Is it likely to face patent challenges?
If prior publications or similar patents exist, challenges could occur, especially if claims are deemed too broad.
4. How does this patent compare to European patents?
It covers Spain only; broader protection may be obtained through a European patent covering multiple countries.
5. What is the remaining patent life?
Assuming a 2016 filing date and standard 20-year term, protection will expire around 2036, barring extensions or adjustments.
References
- European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com/
- WIPO. (2023). PATENTSCOPE. Retrieved from https://patentscope.wipo.int/
- European Patent Office. (2020). Patent ES2726524.
- Smith, J. (2022). Strategic identification of patents in pharmaceutical R&D. Journal of Patents and Innovation, 15(4), 467-483.
